Journal Article Summary
The article discusses the management of obesity and its associated cardiometabolic risks, focusing on the role of a medication combination known as phentermine and extended-release topiramate (phentermine/topiramate ER). Obesity is a growing global health concern, with significant increases in prevalence leading to various health complications, including diabetes and cardiovascular diseases. The study highlights the need for effective long-term treatment options, especially since many patients do not receive adequate medical advice or intervention for their obesity.
The authors reviewed clinical trials and data regarding the efficacy and safety of phentermine/topiramate ER in treating obesity. They found that this combination therapy resulted in greater weight loss compared to using either medication alone, with significant improvements in cardiometabolic risk factors such as blood pressure and lipid profiles. The studies indicated that patients using phentermine/topiramate ER achieved a more substantial weight reduction and maintained it better over time compared to those on placebo or monotherapy.
However, the article notes several limitations, including the need for more long-term safety data, particularly concerning cardiovascular risks associated with the medications. Patients should be aware of potential side effects, including mood changes and cognitive issues, and the importance of discussing any concerns with their healthcare provider. It is crucial for individuals considering this treatment to have a thorough discussion with their doctor about the risks and benefits, especially if they have pre-existing health conditions or are of childbearing potential.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Sweeting Arianne N, Tabet Eddy, Caterson Ian D, Markovic Tania P. Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014. DOI: 10.2147/DMSO.S38979. PMID: 24550678. PMCID: PMC3926768.
Featured Pill Pals Product
Topiramate 100 mg Tablet --- Generic For Topamax --- Zydus Pharma
Topiramate 100 mg Tablet — Generic For Topamax — Zydus Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
